Drug company breaks 30 year agreement on patient advertising
Kovac, C.
Bmj 323(7311): 470
2001
ISSN/ISBN: 0959-8138 PMID: 11532830 Document Number: 538765
Document emailed within 1 workday
Related Documents
Middleton, P. 1995: Voluntary agreement of tobacco advertising Bmj 310(6980): 662Hallam, K. 1999: Columbia gets tax breaks. Company wins in challenges of fair market value of Virginia hospitals Modern Healthcare 29(33): 6
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Hoaken, P.C. 2001: Misleading drug advertising Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46(7): 660-661
1971: Advertising of stimulant drug Medical Journal of Australia 2(24): 1214
Blöcher, D. 1982: DNA double strand breaks in Ehrlich ascites tumour cells at low doses of x-rays. I. Determination of induced breaks by centrifugation at reduced speed International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 42(3): 317-328
Black, R.C.; Calvert, J. 2008: Medicaid and the Frew agreement--a year in review Texas Dental Journal 125(10): 1006 1008
Welsh, J.S. 1980: Keeping prescription drug advertising honest. FDA's watchful eye American Pharmacy 20(5): 40-44
Reichert, T. 2002: Sex in advertising research: a review of content, effects, and functions of sexual information in consumer advertising Annual Review of Sex Research 13: 241-273
Hastings, G.; MacFadyen, L. 2000: A day in the life of an advertising man: review of internal documents from the UK tobacco industry's principal advertising agencies Bmj 321(7257): 366-371
Hilker, R.R.; Asma, F.E.; Eggert, R.L. 1972: A company-sponsored alcoholic rehabilitation program. Ten year evaluation Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 14(10): 769-772
Pfeil-Doyle, J.L.; Jones, M.D.; Oberlin, J.A.; Benitez, J. 1990: Drug information services at Eli Lilly and Company American Journal of Hospital Pharmacy 47(9): 1996-1998
Thompson, R.S. 1998: Impact of patient-directed pharmaceutical advertising American Family Physician 57(7): 1499
De Groot, H.; van Herten, J. 2006: The new veterinary drug agreement and the new veterinary drug rules 2005: what does that mean for your practice? Tijdschrift Voor Diergeneeskunde 131(1): 14-17
Maehara, Y.; Anai, H.; Kusumoto, T.; Sakaguchi, Y.; Emi, Y.; Kohnoe, S.; Sugimachi, K. 1989: Detection of cellular DNA strand breaks induced by antitumor drug and heat using in situ nick translation Nihon Geka Gakkai Zasshi 90(9): 1576-1578
Tanne, J.Hopkins. 2009: US university psychiatrist loses chairmanship over drug company payments Bmj 338: A3188
Kang, G. 2010: HPV vaccines: separating real hope from drug company hype Indian Journal of Medical Ethics 7(1): 56-57
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138
Lazar, E.J.; Banks, D.; Graham, C.; Adams, D.; Rheinstein, P.H.; Gross, M.; Witt, A.M. 1992: Drug company sponsorship of education: the response to the FDA draft concept paper JAMA 268(1): 53-54